Drug information provided by: Merative, Micromedex®
Faricimab-svoa injection is used to treat neovascular (wet) age-related macular degeneration (AMD). AMD is a disorder of the retina in the eye that causes blurring of vision or blindness. Faricimab-svoa works by changing the amount of blood that gets to the eye.
Faricimab-svoa injection is also used to treat diabetic macular edema (swelling of the back of the eye). It is also used to treat macular edema after retinal vein occlusion (blocked blood vessel in the eye). Macular edema can cause loss of vision.
This medicine is to be given only by or under the direct supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.